As of close of business last night, Olema Pharmaceuticals Inc’s stock clocked out at $10.85, down -0.09% from its previous closing price of $10.86. On the day, 676249 shares were traded.
Ratios:
To gain a deeper understanding of OLMA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.33 and its Current Ratio is at 12.33. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on April 02, 2024, initiated with a Buy rating and assigned the stock a target price of $24.
On January 30, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $20.
On July 21, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $21.Oppenheimer initiated its Outperform rating on July 21, 2023, with a $21 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 28 ’24 when Harmon Cyrus sold 20,000 shares for $10.97 per share. The transaction valued at 219,400 led to the insider holds 826,283 shares of the business.
Harmon Cyrus sold 25,000 shares of OLMA for $310,309 on Feb 29 ’24. The Director now owns 846,283 shares after completing the transaction at $12.41 per share. On Feb 01 ’24, another insider, Harmon Cyrus, who serves as the Director of the company, sold 5,000 shares for $15.56 each. As a result, the insider received 77,800 and left with 871,283 shares of the company.
Stock Price History:
Over the past 52 weeks, OLMA has reached a high of $17.79, while it has fallen to a 52-week low of $3.53.
Shares Statistics:
A total of 54.99M shares are outstanding, with a floating share count of 48.58M. Insiders hold about 13.13% of the company’s shares, while institutions hold 86.74% stake in the company.
Earnings Estimates
As of right now, Loma Negra Compania Industrial analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $10.85, with high estimates of $7.31 and low estimates of $20.56.
